Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-29T18:01:46.510Z Has data issue: false hasContentIssue false
  • English
  • Français

Descriptive Evaluation of a Smoking Cessation Support Service for Chronic Disease Clients Within a Hospital Admissions Risk Program

Published online by Cambridge University Press:  15 June 2015

Pam Shields ,
Robyn Bradley ,
Marnie Graco  and
A. Hutchinson
Pam Shields*
Affiliation:
Northern Alliance HARP, Melbourne, Victoria, Australia
Robyn Bradley
Affiliation:
Northern Alliance HARP, Melbourne, Victoria, Australia
Marnie Graco
Affiliation:
Northern Clinical Research Centre, Melbourne, Victoria, Australia
A. Hutchinson
Affiliation:
Northern Clinical Research Centre, Melbourne, Victoria, Australia
*
Address for correspondence: Pam Shields, BN, B Psych (Hons), Respiratory Nurse Consultant/Smoking Cessation Facilitator Northern HARP Alliance, Melbourne Victoria, Australia. Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction: The Northern Alliance HARP smoking cessation program provides support to chronic disease participants who desired to quit smoking. This is an individualised program with pharmacotherapy and behavioural support, delivered by specialist clinicians.

Aims: The aims of this descriptive evaluation were to explore factors that affect abstinence rates, record those rates, and describe the impact of anxiety, depression, self-efficacy, quality of life and motivation on quit rates at three months.

Methods: Data was collected prospectively from clients enrolled in the service. Participants were assessed for abstinence at three months, six months and one year by carbon monoxide (CO) monitoring and self-reporting. Factors predictive of quitting were analysed using logistic regression; factors with a p value < 0.05 and 95% CI not containing one were considered statistically significant.

Results: 103 clients were assessed and 86 were enrolled in the program. The odds of successful quitting at three months CO verified was higher amongst completers of the program compared to non-completers (OR = 6.6, 95% CI = 2.03–21.57, p = 0.002). The probability of sustained quitting at one year was over 18 times higher in the group who completed the program (n = 16/21 completers and n = 1/4 non-completers) (OR 18.5, 95% CI, 2.32–147.34, p = 0.006). No other factors predicted quitting.

The rate of quitting was 28.7% at three months, 19.5% at six months and 10.3% at one year, CO verified. Measures of anxiety and depression, self-efficacy, quality of life and motivation did not influence either the quit rate or the likelihood of completing the course of treatment at three months.

Type
Review Article
Information
Journal of Smoking Cessation , Volume 12 , Issue 1 , March 2017 , pp. 22 - 31
Copyright
Copyright © The Author(s) 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Andersson, C. L. (2001). The New York Heart Association (NYHA) Functional Classification in a Patientwith Heart Disease. Retrieved april 8, 2014, from http://www.cebp.nl/media/m149.pdf.Google Scholar
Anthonisen, N. (1997). Epidemiology and the lung health study. European Respiratory Review, 7 (45), 202–205.Google Scholar
Anthonisen, N. R., Connect, J. E., & Murray, R. P. (2002). Smoking and lung function of lung health study participants after 11 years. American Journal Respiratory Critical care Medicine, 166, 675–679. doi:10.1164/rccm.2112096 CrossRefGoogle Scholar
Aubin, H., Bobak, A., Britton, J. R., Oncken, C., Billing, C., Gong, J. Jr. et al. (2008). Varenicline verses Transdermal nicotine patch for smoking cessation: Results from a randomised, open- label trial. Thoraxonline. Retrieved from http://thorax.bmj.com/cgi/content/abstract/thx.2007.090647v1.Google Scholar
Benowitz, N. (2009). Pharmacology of nicotine addiction smoking induced disease and therapeutics. Annual Review of Pharmacology and Oxology, 49, 57–71. doi:10.1146/annurev.pharmtox.48.113006.094742 Google Scholar
Benowitz, N., Jacob, P., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J. et al. (2002). Biochemical verification of tobacco use and cessation. Nicotine and Tobacco Research, 4, 149–159. doi:10.1080/14622200210123581 CrossRefGoogle Scholar
Berlowitz, D. J. & Graco, M. (2010). The development of a streamlined, coordinated and sustainable evaluation methodology for a diverse chronic disease management program. Australian Health Review, 34 (2), 148–151.Google Scholar
Beyondblue (2013). Beyond Blue depression and anxiety older people. Retrieved august 1st, 2013, from Beyond Blue depression and anxiety: http://www.beyondblue.org.au/resources/for-me/olderpeople.Google Scholar
Bittoun, R. (2005). Smoking Cessation Workshop Course Notes. Lung Health Promotion Centre at the Alfred. September 2005. 1–40.Google Scholar
Bittoun, R. (2006). A Combination Nicotine replacement Therapy (NRT) Algorithm for Hard-to-treat smokers. Journal of Smoking Cessation, 1 (1), 3–6.Google Scholar
Bittoun, R. (2007). The ‘treatment-resistant’ smoker. Medicine Today, 8 (8), 16–25.Google Scholar
Bittoun, R. (2008). Carbon monoxide meter: The essential clinical tool-the “Stethoscope”-of smoking cessation. Journal of Smoking Cessation 3 (2), 69–70.Google Scholar
Brandt, C. J., Ellegaard, H., Joensen, M., Kallan, F. V., Sorknaes, A. D., & Tougaard, L. (1997). Effect of diagnosing” smokers lung”. The Lancet, 349, 253.Google Scholar
Buckley, C., O’Dowd, D., Gannon, K., & Brennan, M. (2006). A naturalistic study of an Australian smoking cessation model in a victorian community health service with 12-month follow-up. Journal of Smoking Cessation, 2 (2), 54–58.Google Scholar
Burton, S. M. & Tiffany, S. T. (1997). The effect of alcohol consumption on craving to smoke. Addiction, 92 (1), 15–26.Google Scholar
Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013). Pharmacological interventions for smoking cessation: An overview and network meta-analysis. The Cochrane Library, 5. CD009329. doi:10.1002/14651858.CD009329.pub2 Google Scholar
Chapman, S., & McKenzie, R. (2010). The global research neglect of unassisted smoking cessation: Causes and consequences. PLOS Medicine, 7 (2), 1–6.Google Scholar
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., . . . O'Neill, B. T. (2005). Varenicline: An alpha 4 Beta 2 nicotinic receptor partial agonist for smoking cessation. Journal of Medical Chemistry, 48 (10), 3474–3477.CrossRefGoogle ScholarPubMed
Dawson, G. W. & Vestal, R. E. (1981). Smoking and drug metabolism. Pharmocology and Theraputics, 15, 207–221.Google Scholar
Fagerstrom, K. O., Kunze, M., Schoberberger, R., Breslau, N., Hughes, J. R., . . . Zatonski, W. (1996). Nicotine dependence verses smoking prevelence: Comparisons among countries and categories of smokers. Tobacco Control, 5, 52–56. doi:10.1136/tc.5.1.52 Google Scholar
Ferguson, J. B. (2005). The English smoking treatment service:one year utcomes. Addiction, 100 (2), 59–62.Google Scholar
Ferguson, S. G., Shiffman, S., & Gitchell, J. G. (2011). Nicotine replacement therapies; patient outcome and safety. Patient Related Outcome Measures, 2, 111–117. doi:10.2147/PROM.S11545 Google Scholar
Fiore, M., & Baker, T. (2011). Treating smokers in the health care setting. The New England Journal of Medicine, 365 (13), 1222–1231.Google Scholar
Galbraith, L. (2010). NHS Smoking Cessation service statistics (Scotland). 1st January to 31st December 2009. http://www.scotpho.org.uk/home/Publications/scotphoreports/pub_smokingcessationstats2009.asp Google Scholar
Gellert, C., Schottker, B., & Brenner, H. (2012). Smoking and all-cause mortality in older people: systematic review and meta-analysis. Archives of Internal Medicine, 172 (11), 837–844. doi:10.1001/archinternmed.2012.1397 CrossRefGoogle ScholarPubMed
Global Initiative for Chronic Obstructive Pulmonary Disease (2011). Global strategy for the diagnosis, management and prevention of Chronic Obstructive Pulmonary Disease. Available from: http://www.goldcopd.org/.Google Scholar
Heatherton, T. K. (1991). The fagerstrom test for nicotine dependence: A revision of the fagerstrom tolerance questionnaire. British Journal of Addictions, 86 (11), 19–27.Google Scholar
Ischaki, E., & Gratziou, C. (2009). Smoking and depression: Is smoking cessation effective? Therapeutic Advances in Respiratory Disease, 3 (1), 31–38.CrossRefGoogle ScholarPubMed
Khan, M., & Richardson, J. (2010). Smoking Status and Quality of life: Preliminary results from a sample of Adult Smokers who called Quitline. Melbourne: Monash University.Google Scholar
McLeod, S. (2007). Pavlov's Dogs. Retrieved august 18, 2014, from http://simplypsychology.org/pavlov.html.Google Scholar
McLeod, S. (2007). Skinner-Operant Conditioning. Retrieved august 18, 2014, from http://www.simplypsychology.org/operant-conditioning.html.Google Scholar
McKenzie, D. K., Frith, P. A., Burdon, J. G. W, & Town, G. I (2011). The COPD-X Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003. MJA 2003 178(6 Suppl 17 Mar), S1–S40. www.mja.com.au/public/issues/178_06_170303/tho10508_all.html.Google Scholar
Mendelsohn, C. (2011). Nicotine dependence: Why is it so hard to quit? Medicine Today 12 (10), 35–39.Google Scholar
Miller, W. R., & Rollnick, S. (2002). Motivational Interviewing Preparing People for Change 2nd edn. London, New York: The Guilford Press.Google Scholar
NICE (2014). Guidelines for smoking cessation. Retrieved from NICE: www.nice.org.au, 6th Aug, 2014.Google Scholar
Piper, M. S. (2009). A randomised placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies. Archives of General Psychiatry, 66 (11), 1253–1262.CrossRefGoogle ScholarPubMed
Richardson, J., Khan, M. A., Ghen, G. & Iezzi, A. (2012). Population norms and Australian profile using the Assessment of Quality of Life (AQoL) 8D utility instrument. Melbourne: Monash University.Google Scholar
Schwarzer, R., & Jerusalem, M. (1995). Generalized self-efficacy scale. In Weinman, J., Wright, S. (Eds.), Measures in health psychology: A user's portfolio. Causal and control beliefs (pp. 35–37). Windsor England: NFER-NELSON.Google Scholar
The Department of Human Services (2004). Hospital Admission Risk Program. Retrieved: http://www.health.vic.gov.au/archive2005/harp/pubrep0304.pdf:www.health.vic.gov.au/hdms/harp/.Google Scholar
The Department of Human Services (2014). (Last updated: 16 January, 2014. http://docs.health.vic.gov.au/docs/doc/HARP-Eligibility-criteria. Retrieved April 8, 2014, from http://www.health.vic.gov.au/harp/about.htm#background: http://docs.health.vic.gov.au/docs/doc/HARP-Eligibility-Criteria.Google Scholar
Tonnesen, P., Carrozzi, L., Fagerstrom, K. O., Gratziou, C., Jimenez-Ruiz, C., Nardini, S. et al. (2007). Smoking cessation in patients with respiratory diseases: A high priority, integral component of therapy. European Respiratory Journal, 29 (2), 390–417.Google Scholar
Tonnessen, P. (2009). Smoking cessation: How compelling is the evidence? A review. Science Direct Health Policy Supplement 1, s15–s25.Google Scholar
West, R. (2004). ABC of smoking cessation: Assessment of dependence and motivation to stop smoking. British Medical Journal, 328, 338–339. doi:http://dx.doi.org/10.1136/bmj.328.7435.338 Google Scholar
Windsor, UK: NFER-NELSON (2008). Smoking cessation services in primary care, pharmacies, local authorities and work places particularly for manual working groups, pregnant women and hard to reach communities. (2008, Feb). Retrieved from www.nice.org.uk/PH010.Google Scholar
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370. doi:10.1111/j.1600-0447.1983.tb09716.x Google Scholar
Zwar, N. (2008). Smoking cessation what works? Australian Family Physician, 37 (1/2), 10–14.Google Scholar
Zwar, N., Richmond, R., Borland, R., Peters, M., Litt, J., Bell, J. et al. (2011). Supporting Smoking Cessation: A Guide for Health Professionals. Melbourne: The Royal Australian College of General Practitioners.Google Scholar